Cellectis (CLLS) Change in Cash (2015 - 2026)
Cellectis' (CLLS) quarterly Change in Cash came in at -$26.5 million in Q1 2026, down 55.48% year-on-year from -$59.5 million in Q1 2025, and down 433.06% quarter-over-quarter from $7.9 million in Q4 2025.
Cellectis (CLLS) Change in Cash (2015 - 2026) Analysis & Trends
Cellectis' Change in Cash history runs 12 years deep, the most recent figure standing at -$26.5 million for Q1 2026.
- On a quarterly basis, Change in Cash fell 55.48% year-over-year to -$26.5 million in Q1 2026; TTM through Mar 2026 was -$95.1 million, a 1757.56% decrease from a year earlier, with the FY2025 full-year figure at -$85.6 million, down 1021.43% from the prior year.
- Change in Cash retreated to -$26.5 million in Q1 2026 per CLLS's latest filing, from $7.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $67.6 million in Q4 2023 and bottomed at -$67.3 million in Q2 2025.
- The 5-year median for Change in Cash is -$13.5 million (2024), against an average of -$8.8 million.
- Across the five-year window, Change in Cash surged 2495.06% in 2024 and sank 377.38% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$6.4 million in 2022, then soared by 1152.81% to $67.6 million in 2023, then slumped by 120.37% to -$13.8 million in 2024, then soared by 157.68% to $7.9 million in 2025, then sank by 433.06% to -$26.5 million in 2026.
- Per Business Quant, the three latest CLLS Change in Cash figures stand at -$26.5 million (Q1 2026), $7.9 million (Q4 2025), and -$9.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -26.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.48 Mn |
| Dec 31, 2025 | 7.95 Mn |
| Sep 30, 2025 | -9.27 Mn |
| Jun 30, 2025 | -67.30 Mn |
| Mar 31, 2025 | -17.03 Mn |
| Dec 31, 2024 | -13.78 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Jun 30, 2024 | 24.26 Mn |
| Mar 31, 2024 | -13.47 Mn |
| Dec 31, 2023 | 67.64 Mn |
| Sep 30, 2023 | -15.71 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -8.32 Mn |
| Dec 31, 2022 | -6.43 Mn |
| Sep 30, 2022 | -30.22 Mn |
| Jun 30, 2022 | -22.50 Mn |
| Mar 31, 2022 | -29.92 Mn |
| Dec 31, 2021 | -22.71 Mn |
| Sep 30, 2021 | -36.57 Mn |
| Jun 30, 2021 | 40.35 Mn |